A key recommendation is to incorporate advanced diagnostic techniques, such as MRI and Transcranial Doppler Ultrasound, to improve the accuracy of stroke detection and validate biomarkers like S100B, GFAP and NSE as non-invasive stroke indicators. This evidence concerns the gene ENO2 and stroke disorder.